IOL Chemicals & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 524164 |
NSE Symbol : IOLCP |
P/E(TTM) : 19.07 |
ISIN Demat : INE485C01011 |
Div & Yield% : 1.29 |
EPS(TTM) : 20.25 |
Book Value(₹) : 274.48 |
Market Cap(₹Cr) : 2,267.21 |
Face Value(₹) : 10.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 502.38 | 503.92 | 520.39 | 545.30 | 563.18 | 587.21 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 502.38 | 503.92 | 520.39 | 545.30 | 563.18 | 587.21 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 7.38 | 7.52 | 8.38 | 7.11 | 7.06 | 8.72 |
Total Income | 509.76 | 511.44 | 528.77 | 552.41 | 570.24 | 595.93 |
Total Expenditure | 451.58 | 453.84 | 475.91 | 481.20 | 490.32 | 491.42 |
PBIDT | 58.18 | 57.60 | 52.86 | 71.21 | 79.92 | 104.51 |
Interest | 2.15 | 3.41 | 4.30 | 4.44 | 3.95 | 4.88 |
PBDT | 56.03 | 54.19 | 48.56 | 66.77 | 75.97 | 99.63 |
Depreciation | 16.80 | 16.42 | 16.32 | 15.67 | 14.44 | 12.10 |
Tax | 8.77 | 5.02 | 6.28 | 11.11 | 14.60 | 18.58 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.78 | 4.56 | 2.73 | 2.20 | 0.72 | 3.68 |
Reported Profit After Tax | 29.68 | 28.19 | 23.23 | 37.79 | 46.21 | 65.27 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 29.68 | 28.19 | 23.23 | 37.79 | 46.21 | 65.27 |
EPS (Unit Curr.) | 5.06 | 4.80 | 3.96 | 6.44 | 7.87 | 11.11 |
EPS (Adj) (Unit Curr.) | 5.06 | 4.80 | 3.96 | 6.44 | 7.87 | 11.11 |
Calculated EPS (Unit Curr.) | 5.06 | 4.80 | 3.96 | 6.44 | 7.87 | 11.12 |
Calculated EPS (Adj) (Unit Curr.) | 5.06 | 4.80 | 3.96 | 6.44 | 7.87 | 11.12 |
Calculated EPS (Ann.) (Unit Curr.) | 20.22 | 19.21 | 15.83 | 25.75 | 31.48 | 44.47 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 20.22 | 19.21 | 15.83 | 25.75 | 31.48 | 44.47 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 50.00 | 0.00 | 0.00 | 0.00 |
Equity | 58.71 | 58.71 | 58.71 | 58.71 | 58.71 | 58.71 |
Reserve & Surplus | 1,580.87 | 1,552.62 | 1,553.47 | 1,530.13 | 1,492.82 | 1,447.84 |
Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 11.58 | 11.43 | 10.16 | 13.06 | 14.19 | 17.80 |
PBDTM(%) | 11.15 | 10.75 | 9.33 | 12.24 | 13.49 | 16.97 |
PATM(%) | 5.91 | 5.59 | 4.46 | 6.93 | 8.21 | 11.12 |